422 related articles for article (PubMed ID: 1438242)
1. Construction and characterization of chimeric tick-borne encephalitis/dengue type 4 viruses.
Pletnev AG; Bray M; Huggins J; Lai CJ
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10532-6. PubMed ID: 1438242
[TBL] [Abstract][Full Text] [Related]
2. Chimeric tick-borne encephalitis and dengue type 4 viruses: effects of mutations on neurovirulence in mice.
Pletnev AG; Bray M; Lai CJ
J Virol; 1993 Aug; 67(8):4956-63. PubMed ID: 8331735
[TBL] [Abstract][Full Text] [Related]
3. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
4. Attenuation of the Langat tick-borne flavivirus by chimerization with mosquito-borne flavivirus dengue type 4.
Pletnev AG; Men R
Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1746-51. PubMed ID: 9465088
[TBL] [Abstract][Full Text] [Related]
5. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
[TBL] [Abstract][Full Text] [Related]
6. Construction of intertypic chimeric dengue viruses exhibiting type 3 antigenicity and neurovirulence for mice.
Chen W; Kawano H; Men R; Clark D; Lai CJ
J Virol; 1995 Aug; 69(8):5186-90. PubMed ID: 7609092
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-based control of tick-borne flavivirus neuropathogenesis: Challenges and perspectives.
Teterina NL; Maximova OA; Kenney H; Liu G; Pletnev AG
Antiviral Res; 2016 Mar; 127():57-67. PubMed ID: 26794396
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Langat/dengue 4 chimeric virus as a live attenuated tick-borne encephalitis vaccine for safety and immunogenicity in healthy adult volunteers.
Wright PF; Ankrah S; Henderson SE; Durbin AP; Speicher J; Whitehead SS; Murphy BR; Pletnev AG
Vaccine; 2008 Feb; 26(7):882-90. PubMed ID: 18207289
[TBL] [Abstract][Full Text] [Related]
9. The neurovirulence and neuroinvasiveness of chimeric tick-borne encephalitis/dengue virus can be attenuated by introducing defined mutations into the envelope and NS5 protein genes and the 3' non-coding region of the genome.
Engel AR; Rumyantsev AA; Maximova OA; Speicher JM; Heiss B; Murphy BR; Pletnev AG
Virology; 2010 Sep; 405(1):243-52. PubMed ID: 20594569
[TBL] [Abstract][Full Text] [Related]
10. Safety evaluation of chimeric Langat/Dengue 4 flavivirus, a live vaccine candidate against tick-borne encephalitis.
Pripuzova NS; Tereshkina NV; Gmyl LV; Dzhivanyan TI; Rumyantsev AA; Romanova LIu; Mustafina AN; Lashkevich VA; Karganova GG
J Med Virol; 2009 Oct; 81(10):1777-85. PubMed ID: 19697399
[TBL] [Abstract][Full Text] [Related]
11. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype.
Heiss BL; Maximova OA; Pletnev AG
J Virol; 2011 Feb; 85(4):1464-72. PubMed ID: 21123372
[TBL] [Abstract][Full Text] [Related]
12. Recombinant chimeric Japanese encephalitis virus/tick-borne encephalitis virus is attenuated and protective in mice.
Wang HJ; Li XF; Ye Q; Li SH; Deng YQ; Zhao H; Xu YP; Ma J; Qin ED; Qin CF
Vaccine; 2014 Feb; 32(8):949-56. PubMed ID: 24394443
[TBL] [Abstract][Full Text] [Related]
13. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
14. Chimeric tick-borne encephalitis/dengue virus is attenuated in Ixodes scapularis ticks and Aedes aegypti mosquitoes.
Engel AR; Mitzel DN; Hanson CT; Wolfinbarger JB; Bloom ME; Pletnev AG
Vector Borne Zoonotic Dis; 2011 Jun; 11(6):665-74. PubMed ID: 21142950
[TBL] [Abstract][Full Text] [Related]
15. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
Lai CJ; Monath TP
Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
[TBL] [Abstract][Full Text] [Related]
16. Growth-restricted dengue virus mutants containing deletions in the 5' noncoding region of the RNA genome.
Cahour A; Pletnev A; Vazielle-Falcoz M; Rosen L; Lai CJ
Virology; 1995 Feb; 207(1):68-76. PubMed ID: 7871753
[TBL] [Abstract][Full Text] [Related]
17. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
18. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
Bray M; Men R; Lai CJ
J Virol; 1996 Jun; 70(6):4162-6. PubMed ID: 8648761
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Langat/Dengue viruses protect mice from heterologous challenge with the highly virulent strains of tick-borne encephalitis virus.
Pletnev AG; Karganova GG; Dzhivanyan TI; Lashkevich VA; Bray M
Virology; 2000 Aug; 274(1):26-31. PubMed ID: 10936085
[TBL] [Abstract][Full Text] [Related]
20. The envelope protein of tick-borne encephalitis virus influences neuron entry, pathogenicity, and vaccine protection.
Lindqvist R; Rosendal E; Weber E; Asghar N; Schreier S; Lenman A; Johansson M; Dobler G; Bestehorn M; Kröger A; Överby AK
J Neuroinflammation; 2020 Sep; 17(1):284. PubMed ID: 32988388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
